1192-1193 / 2001
HDR MONOTHERAPY
•
Early experience in advanced cases
suggests high rates of biochemical control
O ti
l i di ti t t b d fi d
•
p ma n ca on ye o e e ne :
?intermediate/high risk…?low risk
A t t i it l
th
d b h th
•
cu e ox c y ess an see rac y erapy
•
Late toxicity profile may also be favourable
with lower rates of late urinary and erectile
dysfunction